Companies / LifeStance Health Group, Inc.
LifeStance Health Group, Inc.
Nasdaq: LFSTCIK 1845257SCOTTSDALE, AZ
Financials · FY2025
Ownership
382.1M shares outstanding · as of Jul 29, 2026
Ownership
| Insiders | 9.51% | 36,330,352 |
| 10%+ / strategic | 41.47% | 158,451,398 |
| Institutions | 50.44% | 192,707,275 |
| Public float | 0.00% | 0 |
Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 12
View all →| Insider | % of shares | Shares |
|---|---|---|
Tpg Gp a, LLC10% owner | 29.25% | 111,744,614 |
Black Darren M.Director | 7.65% | 29,209,776 |
Burdick Kenneth ADirector | 0.90% | 3,425,315 |
Bourdon DavidCEOChief Executive Officer · Director | 0.37% | 1,398,247 |
Pardo RyanSee Remarks · Director | 0.29% | 1,102,742 |
McGroarty RyanSee Remarks | 0.20% | 772,235 |
Varanakis AnnChief People Officer | 0.11% | 422,037 |
Miller Lisa KFormerChief Operating Officer | 0.09% | 329,201 |
Paunovich VukasinFormerChief Technology Officer | 0.08% | 309,296 |
Eken Stephanie CarinFormerChief Medical Officer | 0.03% | 115,107 |
Institutional holders 220
View all →| Holder | Value | % of shares |
|---|---|---|
| $1.13B | 42.06% | |
| $389.29M | 9.51% | |
| $329.72M | 12.26% | |
| $236.01M | 8.77% | |
| $124.61M | 4.63% | |
| $100.84M | 3.75% | |
| $88.13M | 2.15% | |
| $62.70M | 2.33% | |
| $51.99M | 1.93% | |
| $43.07M | 1.60% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q2 2026 as of | BlackRock, Inc. 13F manager | Add | Common Stock | $184.84M | +17.3M +90.41% | 36,348,507 9.51% of shares | high |
| Q2 2026 as of | State Street Corporation 13F manager | Add | Common Stock | $48.89M | +4.6M +124.62% | 8,228,351 2.15% of shares | medium |
| Q3 2024 as of | Barclays PLC 13F manager | Add | Common Stock | $8.33M | +1.2M +1499.93% | 1,268,904 0.33% of shares | medium |
| Q3 2025 as of | Barclays PLC 13F manager | Add | Common Stock | $8.25M | +1.5M +74.65% | 3,508,552 0.92% of shares | medium |
| Q1 2026 as of | First Trust Advisors LP 13F manager | Add | Common Stock | $3.80M | +597K +127.00% | 1,066,191 0.28% of shares | low |
| Q1 2026 as of | D. E. Shaw & Co., Inc. 13F manager | Add | Common Stock | $3.22M | +505K +363.58% | 644,152 0.17% of shares | low |
| Q1 2026 as of | Orbimed Advisors LLC 13F manager | New | Common Stock | $3.19M | +500K | 500,000 0.13% of shares | low |
| Q2 2025 as of | Barclays PLC 13F manager | Add | Common Stock | $3.01M | +582K +40.76% | 2,008,865 0.53% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Fmr LLC | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| LFST | Common Stock | 53228F101 |